title: Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium.
abstract: BACKGROUND
  Complete loss of the corneal-limbal epithelium leads to re-epithelialisation by bulbar conjunctival cells. Since conjunctival and corneal-limbal epithelial cells represent two different cell lines, this conjunctival healing of the cornea is followed by stromal scarring, decreased visual acuity, and severe discomfort. Unilateral corneal-limbal epithelial defects can be resolved by the transplantation of limbal grafts taken from the uninjured eye. However, this procedure requires a large limbal graft to be taken from the healthy eye, and is not possible for bilateral lesions. We investigated the possibility of restoring the human corneal surface with autologous corneal epithelial sheets generated by serial cultivation of limbal cells.
  
  
  METHODS
  Cells were cultivated from a 1 mm2 biopsy sample taken from the limbus of the healthy eye of two patients with severe alkali burns, and thus complete loss of the corneal-limbal surface, of one eye. Normal corneal differentiation was tested with a specific biochemical marker. Autologous cultured corneal sheets were then grafted onto the damaged eyes of the two patients. The patients were followed up at more than 2 years after grafting.
  
  
  RESULTS
  We have shown that corneal progenitor cells are localised in the limbus, that cultured limbal cells generate cohesive sheets of authentic corneal epithelium, and that autologous cultured corneal epithelium restored the corneal surface of two patients with complete loss of the corneal-limbus epithelium. Long-term follow-up showed the stability of regenerated corneal epithelium and the striking improvement in patients' comfort and visual acuity.
  
  
  CONCLUSIONS
  The cultivation of corneal epithelium might offer an alternative to patients with unilateral lesions and a therapeutic chance to patients with severe bilateral corneal-limbal epithelial defects. Our findings give a new perspective on the treatment of ocular disorders characterised by stem-cell deficiency.
authors.affiliation: Istituto Dermopatico dell'Immacolata, Roma, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Pellegrini
authors.forename: C E
authors.initials: CE
authors.lastname: Traverso
authors.forename: A T
authors.initials: AT
authors.lastname: Franzi
authors.forename: M
authors.initials: M
authors.lastname: Zingirian
authors.forename: R
authors.initials: R
authors.lastname: Cancedda
authors.forename: M
authors.initials: M
authors.lastname: De Luca
mesh_terms: D002057:Burns, Chemical / Q000601:surgery*; D002478:Cells, Cultured; D003315:Cornea / Q000166:cytology*; D016039:Corneal Transplantation / Q000379:methods*; D004847:Epithelial Cells; D005126:Eye Burns / Q000139:chemically induced / Q000601:surgery*; D006801:Humans; D016850:Limbus Corneae / Q000166:cytology*; D012038:Regeneration; D014182:Transplantation, Autologous; D014792:Visual Acuity